Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 134, Issue 1, Pages 353-362
Publisher
Springer Nature
Online
2012-03-20
DOI
10.1007/s10549-012-2021-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
- (2011) E. Comen et al. BREAST CANCER RESEARCH AND TREATMENT
- Higher population-based incidence rates of triple-negative breast cancer among young African-American women
- (2011) Kathryn C. Amirikia et al. CANCER
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
- (2011) D. G. Evans et al. JOURNAL OF MEDICAL GENETICS
- PARP inhibitors stumble in breast cancer
- (2011) Malini Guha NATURE BIOTECHNOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
- (2010) Michelle D. Sluiter et al. BREAST CANCER RESEARCH AND TREATMENT
- Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population
- (2010) M Pertesi et al. CLINICAL GENETICS
- Characteristics of triple-negative breast cancer
- (2010) Tim C. de Ruijter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors
- (2010) Janice S. Kwon et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathology of hereditary breast cancer
- (2010) Leonard Da Silva et al. MODERN PATHOLOGY
- Triple-negative breast cancer: Present challenges and new perspectives
- (2010) Franca Podo et al. Molecular Oncology
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers
- (2009) Laura C. Collins et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
- (2009) SR Young et al. BMC CANCER
- Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases
- (2009) S Armaou et al. BRITISH JOURNAL OF CANCER
- Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase
- (2009) E. Alli et al. CANCER RESEARCH
- Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
- (2009) Dezheng Huo et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
- (2008) G. Fountzilas et al. BREAST CANCER RESEARCH AND TREATMENT
- Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study
- (2008) Christos A. Papadimitriou et al. CANCER INVESTIGATION
- Advances in Breast Cancer: Pathways to Personalized Medicine
- (2008) O. I. Olopade et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- What is triple-negative breast cancer?
- (2008) William J. Irvin et al. EUROPEAN JOURNAL OF CANCER
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started